Evidence map›Paper›PMID 36619271›Full record

ArticleMiddle East journal of digestive diseases2022

The Correlation between New Serological Markers and Disease Phenotype and Activation in Inflammatory Bowel Disease.

Elif Yorulmaz, Gupse Adalı, Hatice Yorulmaz, Güralp Taşan, Seval Gürses, Mehmet Ramazan Ayaş, İlyas Tuncer

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Middle East journal of digestive diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.1field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Prevalence of Anti-Pathogens (Basel, Switzerland) · 2025
    Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 1 country.

Elif YorulmazDepartment of Gastroenterology, University of Health Sciences, Bağcılar Training and Research Hospital, Istanbul, Turkey.
Gupse AdalıDepartment of Gastroenterology, University of Health Sciences, Umraniye Training and Research Hospital, Istanbul, Turkey.
Hatice YorulmazFaculty of Health Sciences, Haliç University, Eyüp, İstanbul, Turkey.
Güralp TaşanDepartment of Gastroenterology, Istanbul Medeniyet University, School of Medicine, Goztepe, Istanbul, Turkey.
Seval GürsesDepartment of Biology, Trakya University, Edirne, Turkey.
Mehmet Ramazan AyaşDepartment of Biology, Marmara University, Istanbul, Turkey.
İlyas TuncerDepartment of Gastroenterology, Istanbul Medeniyet University, School of Medicine, Goztepe, Istanbul, Turkey.
Istanbul Medeniyet University · TRSağlık Bilimleri Üniversitesi · TRHaliç University · TRMarmara University · TRTrakya University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antiglycan antibodiesCrohn’s diseaseUlcerative colitis

Identifiers

PMID36619271
PMCPMC9489435
OpenAlexW4312233463

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.